abstract |
The invention provides novel rapamycin water-soluble pegylated esters, having the general structure (I) (see formula) wherein n is an integer from about 5 to about 450, as well as pharmaceutical compositions containing these compounds and methods for use as agents. immunosuppressants, anti-inflammatory, antifungal, antiproliferative and antitumor agents. |